

Decentralized Clinical Trials in the EU: Accelerating the Development of New Medicines
The European Medicines Agency (EMA) is working to facilitate decentralized clinical trials (DCTs) in the EU. DCTs are a type of clinical trial that uses remote monitoring and other technologies to allow patients to participate in trials from their homes or other convenient locations. This approach has the potential to make clinical trials more accessible to a wider range of patients, and to reduce the cost and time of drug development.